- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States
- Goshen Center for Cancer Care IU Cancer Center Indianapolis, Indiana, United States
- University of Kansas Hospital and Medical Center SC - Univ KS Kansas City, Kansas, United States
- Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
Clinical trial condition
Bone Marrow Diseases
Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.
3,008 public trials
530 recruiting studies
Bone Marrow Diseases trial results
Completed
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
NCT00006083
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00079222
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00064233
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT01235572
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +31 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01602211
- Conditions
- Behavior, Behavioral Symptoms, Bone Marrow Diseases, +10 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
NCT00822393
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Helsinki University Central Hospital, Dept. of Medicine Helsinki, Finland
- Centre Hospitalier Lyon Sud Lyon, France
- Hopital Saint-Louis Paris, France
- Universitätsklinikum Koeln, Stammzelltransplantation Cologne, Germany
NCT02689622
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- Hôpital Sud Amiens, France
- Chu Angers Angers, France
- CH Annecy Annecy, France
- CH Henri Duffaut Avignon, France
NCT00068523
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00274820
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +16 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States